| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/29/2007 | US20070072267 Transformant having galactose induction system and use thereof |
| 03/29/2007 | US20070072263 DNA19355 polypeptide, a tumor necrosis factor homolog |
| 03/29/2007 | US20070072261 Nucleic acids encoding PAK5 polypeptidesm and methods of use thereof |
| 03/29/2007 | US20070072260 Mixture comprising serum complement system protein (INSP163) use in preparation of vaccines and antibodies for treatment and prevention of infection, cell proliferative, skin, neurodegenerative, bone, inflammatory, respiratory system and autoimmune disorders |
| 03/29/2007 | US20070072236 Novel type II Na/Pi cotransporters and type II Na/Pi cotransporter expression regulatory factors |
| 03/29/2007 | US20070072231 Tumor suppressor gene |
| 03/29/2007 | US20070072221 Methods to screen peptide display libraries using minicell display |
| 03/29/2007 | US20070072217 XAF genes and polypeptides: methods and reagents for modulating apoptosis |
| 03/29/2007 | US20070072214 Two or three markers (preferably N-terminal and C-terminal epitopes) are introduced into the nascent protein and the resulting wild-type and mutant proteins are detected by mass spectrometry; facilitate detection and analysis of nascent proteins translated within cellular or cell-free translation system |
| 03/29/2007 | US20070072204 Compositions and methods for cancer diagnosis and treatment |
| 03/29/2007 | US20070072198 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 03/29/2007 | US20070072194 Global transcription machinery engineering |
| 03/29/2007 | US20070072191 Infectious pestivirus pseudo-particles containing functional erns, e1, e2 envelope proteins |
| 03/29/2007 | US20070072189 Artificial mutation controls for diagnostic testing |
| 03/29/2007 | US20070072185 Carbohydrate-binding modules of a new family |
| 03/29/2007 | US20070072183 Topoisomerase hybrids and methods of use |
| 03/29/2007 | US20070072176 Novel peptide compositions and their use in particular in the preparation of pharmaceutical compositions active against the hepatitis C virus |
| 03/29/2007 | US20070072172 Liver specific chimeric regulatory sequence and use thereof |
| 03/29/2007 | US20070072171 Solid surface for biomolecule delivery and high-throughput assay |
| 03/29/2007 | US20070071827 Polypeptides and Polynucleotides for Enhancing Immune Reactivity to HER-2 Protein |
| 03/29/2007 | US20070071823 complexing amphoteric polymers with polynucleotides and delivering the complex into cells |
| 03/29/2007 | US20070071774 Protein D - an IgD-binding protein of Haemophilus influenzae |
| 03/29/2007 | US20070071770 Recombinant MVA virus, and the use thereof |
| 03/29/2007 | US20070071769 Recombinant MVA virus, and the use thereof |
| 03/29/2007 | US20070071752 Sphingosine kinase enzyme |
| 03/29/2007 | US20070071742 bind ICAM-1 and inhibit pathogen infection of cells expressing ICAM-1; for protection against human rhinovirus (HRV), coxackie A virus, respiratory syncytial virus (RSV), or malaria |
| 03/29/2007 | US20070071730 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 03/29/2007 | US20070071726 replication-defective recombinant adenovirus comprising a heterologous nucleic acid sequence encoding an antigenic determinant of Plasmodium falciparum; ntigenic determinant comprises an immunogenic peptide of the circumsporozoite protein; viral vectors |
| 03/29/2007 | US20070071725 Nitric oxide synthase gene transfer |
| 03/29/2007 | US20070071677 Non-toxic membrane-translocating peptides |
| 03/29/2007 | US20070071674 Polynucleotides encoding novel isoforms of IGSF9 |
| 03/29/2007 | DE102005046490A1 New nucleic acid molecule comprising promoter, a transcriptable nucleic acid sequence, a first and second nucleic acid sequence for producing modified RNA with transcriptional stability and translational efficiency |
| 03/29/2007 | DE102005046348A1 New heat-stable enzyme with 3'-5'-exonuclease activity, useful e.g. for preparing templates for dideoxy sequencing and directed mutagenesis, also new nucleic acid encoding it |
| 03/29/2007 | DE10106163B4 Verfahren zur Herstellung von Kohlenhydraten A process for producing carbohydrates |
| 03/29/2007 | DE10006591B4 Verfahren zur Aufreinigung von Nukleinsäuren A method for purifying nucleic acids |
| 03/29/2007 | CA2812343A1 Methods for genetic control of insect infestations in plants and compositions thereof |
| 03/29/2007 | CA2641329A1 Transgenic pig with diabetes and method for producing the same |
| 03/29/2007 | CA2623772A1 Modulation of glucocorticoid receptor expression |
| 03/29/2007 | CA2623762A1 Modulation of glucagon receptor expression |
| 03/29/2007 | CA2623490A1 Snrna gene-like transcriptional units and uses thereof |
| 03/29/2007 | CA2623424A1 Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics |
| 03/29/2007 | CA2623268A1 Melting curve analysis with exponential background subtraction |
| 03/29/2007 | CA2623266A1 Low acrylamide foods and their production comprising reduction of asparagine levels in plants |
| 03/29/2007 | CA2623153A1 The use of sirnas in organ storage/reperfusion solutions |
| 03/29/2007 | CA2622710A1 Hybrid portable origin of replication plasmids |
| 03/29/2007 | CA2622687A1 Methods for genetic control of insect infestations in plants and compositions thereof |
| 03/29/2007 | CA2622629A1 Aptamers as agonists |
| 03/29/2007 | CA2622422A1 Methods for screening for compounds that modulate insulin promoter activity |
| 03/29/2007 | CA2622037A1 Method for isolating nucleic acids |
| 03/29/2007 | CA2621328A1 Gene encoding cell wall mannoprotein and use thereof |
| 03/29/2007 | CA2620081A1 Cdna library preparation |
| 03/29/2007 | CA2561458A1 Ct determination by cluster analysis with variable cluster endpoint |
| 03/28/2007 | EP1767654A1 Novel test method for taste abnormality |
| 03/28/2007 | EP1767653A1 Probe for diagnosis of marfan's syndrome and method of screening with the probe |
| 03/28/2007 | EP1767652A1 Gene marker and utilization of the same |
| 03/28/2007 | EP1767650A1 Method of screening compound directly activating glycogen synthase |
| 03/28/2007 | EP1767649A1 Assay of ubiquitinization of synoviolin and use thereof in screening |
| 03/28/2007 | EP1767646A1 Probe for detection/determination of inositol-1,4,5-triphosphoric acid and method of detecting/determining inositol-1,4,5-triphosphoric acid with the same |
| 03/28/2007 | EP1767643A1 Host cells and methods for the cytoprotection from oxidative and nitrosative stress |
| 03/28/2007 | EP1767642A1 Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof |
| 03/28/2007 | EP1767641A1 Antigenic neisserial peptides |
| 03/28/2007 | EP1767640A1 Process for producing protein a-like protein with use of brevibacillus genus bacaterium |
| 03/28/2007 | EP1767639A1 Oral vaccine against protozoiasis using genetically modified plant |
| 03/28/2007 | EP1767638A2 Mutation associated with epilepsy |
| 03/28/2007 | EP1767637A1 Mutation associated with epilepsy |
| 03/28/2007 | EP1767636A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 03/28/2007 | EP1767635A1 Fluorescent protein |
| 03/28/2007 | EP1767634A1 Novel galectin 8 modification protein and use thereof |
| 03/28/2007 | EP1767633A1 Novel polypeptide useful for diagnosis and treatment of cancer |
| 03/28/2007 | EP1767632A2 A method for local administration of synthetic double-stranded oligonucleotides targeting a VEGF receptor |
| 03/28/2007 | EP1767631A1 A method for isolating RNA |
| 03/28/2007 | EP1767630A1 Apparatus for disrupting cells or viruses using laser and magnetic beads |
| 03/28/2007 | EP1767629A2 Methods for the detection, analysis and isolation of nascent proteins |
| 03/28/2007 | EP1767628A1 Process for producing dipeptides or dipeptide derivatives |
| 03/28/2007 | EP1767627A1 Anti-perp antibody |
| 03/28/2007 | EP1767626A1 Peroral vaccine carrier system |
| 03/28/2007 | EP1767625A1 Activity regulator for interferon producing cell |
| 03/28/2007 | EP1767624A1 Improved nitrile hydratase |
| 03/28/2007 | EP1767623A1 Container for nucleic acid extraction, method of cleaning solid matrix and relevant cleaning mechanism, and method of purifying nucleic acid |
| 03/28/2007 | EP1767622A1 Plasmid responsive to dioxin, etc., transgenic cell for assay of dioxin, etc. and utilizing the same, dioxin, etc. detecting method and biosensor |
| 03/28/2007 | EP1767621A1 Method of purifying environmental dna and method of efficiently screening protein-encoding gene from environmental dna |
| 03/28/2007 | EP1767546A1 Angiogenesis-inhibiting chimeric protein and the use |
| 03/28/2007 | EP1767544A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 |
| 03/28/2007 | EP1767543A1 Novel bee venom polypeptides and methods of use thereof |
| 03/28/2007 | EP1767542A2 HLA-A2. 1 binding peptides and their uses |
| 03/28/2007 | EP1767192A2 Cationic lipid compositions targeting angiogenic endothelial cells |
| 03/28/2007 | EP1766768A2 Use of lacritin in promoting ocular cell survival |
| 03/28/2007 | EP1766601A2 Genetically purified gellan gum |
| 03/28/2007 | EP1766411A2 Method for determining a tissue degradation process by detection of comp neoepitopes |
| 03/28/2007 | EP1766096A2 Siv and hiv vaccination using rhcmv- and hcmv-based vaccine vectors |
| 03/28/2007 | EP1766094A2 Influenza virus vaccine composition and method of use |
| 03/28/2007 | EP1766085A2 Aptamer-nanoparticle conjugates and method of use for target analyte detection |
| 03/28/2007 | EP1766082A2 Cog47 protein and s100beta gene polymorphism |
| 03/28/2007 | EP1766073A1 Enhancing protein expression |
| 03/28/2007 | EP1766071A2 Double strand compositions comprising differentially modified strands for use in gene modulation |
| 03/28/2007 | EP1766065A2 COMPOSITIONS AND METHODS FOR SYNTHESIZING cDNA |
| 03/28/2007 | EP1766058A2 Polynucleotides and polypeptides involved in plant fiber development and methods of using same |
| 03/28/2007 | EP1766054A1 Compositions and methods |
| 03/28/2007 | EP1766052A1 Chimeric gapped oligomeric compositions |
| 03/28/2007 | EP1766044A2 Methods and kits to increase the efficiency of oligonucleotide-directed nucleic acid sequence alteration |